Global life sciences outlook 2020

Deloitte Insights

2020 global life sciences outlook

Creating new value, building blocks for the future

As the sector moves toward a future of data-driven technologies, this year’s global life sciences sector outlook tries to answer questions around creating new value, leveraging opportunities, and investing in the future.

Creating new value, building blocks for the future

BIOPHARMA and medtech organizations are in the fast lane, headed toward a future driven by evolving, data-driven technologies. As organizations strive to make sense of all the data signals, is it time to take a break to refuel and rethink what is being measured? In a rapidly changing world, what metrics really matter?

To find the next generation of key performance indicators, there are several questions organizations could be asking: What can be done to reduce complexity in the patient experience? What is the next level of performance, and how to get there in the next year? Is there adequate visibility of products, costs, and operations to help make timely, informed decisions? Is there a need to acquire, build, or partner for additional capabilities?

Read more on Deloitte Insights


Greg Reh
United States

PDF - 860 KB
Did you find this useful?